Oryzanol Market Report 2026

The oryzanol market size has grown rapidly in recent years. It will grow from $3.21 billion in 2025 to $3.58 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to rising consumption of rice bran oil, growing awareness of antioxidant benefits, expansion of nutraceutical product launches, increased use in cholesterol management supplements, availability of food-grade extraction technologies.

The oryzanol market size is expected to see rapid growth in the next few years. It will grow to $5.56 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to growing demand for plant-based nutraceuticals, rising investments in functional ingredient research, expansion of preventive healthcare nutrition, increasing adoption in sports nutrition products, growing cosmetic industry demand for natural actives. Major trends in the forecast period include increasing use of oryzanol in functional foods, rising demand for antioxidant-rich supplements, growing adoption in cosmetic formulations, expansion of fortified food applications, enhanced focus on natural and plant-based ingredients.

The growing emphasis on health and wellness among consumers is expected to drive the growth of the oryzanol market in the coming years. Health and wellness focus refers to the increasing importance placed on maintaining and improving physical, mental, and emotional health. This shift is fueled by heightened awareness of the link between physical and mental well-being, prompting individuals to adopt holistic approaches through informed lifestyle choices such as dietary trends, mindfulness practices, and stress management. Oryzanol supports health and wellness by functioning as a natural antioxidant, reducing inflammation, and helping lower cholesterol levels. For instance, in November 2023, the Global Wellness Institute, a US-based nonprofit organization, reported that the wellness economy reached $5.6 trillion in 2022, a 27% increase since the pandemic, and is expected to grow to $8.5 trillion by 2027 at an annual rate of 8.6%. In 2022, North Americans spent an average of $5,108 per capita on wellness, compared to $1,596 in Europe. As a result, the increasing consumer focus on health and wellness is propelling the growth of the oryzanol market.

The rising prevalence of cardiovascular disease is expected to drive the growth of the oryzanol market in the coming years. Cardiovascular disease (CVD) encompasses a range of disorders affecting the heart and blood vessels, and its incidence is rising due to factors such as increasing obesity, smoking, and poor dietary habits. Oryzanol contributes to reducing the risk of cardiovascular diseases by lowering LDL (low-density lipoprotein) cholesterol, decreasing inflammation and oxidative stress in the arteries, and promoting better blood circulation. For example, in October 2024, the Centers for Disease Control and Prevention (CDC) reported that heart disease was responsible for 702,880 deaths in 2022, with one death occurring every 33 seconds due to CVD. Projections indicate that by 2030, CVD-related deaths may surpass 23 million globally. Consequently, the growing prevalence of cardiovascular disease is fueling the expansion of the oryzanol market.

Key players in the gamma oryzanol market are concentrating on product innovations, such as advanced formulations and various bioactive compounds and delivery methods, to maximize the nutritional benefits of this bioactive compound and align with the growing consumer focus on health and wellness. These innovations involve combining gamma oryzanol with other potent bioactive compounds, such as aged garlic extract and nano curcumin, to manage cholesterol levels and improve heart health, particularly in younger individuals experiencing increasing cardiovascular concerns. For example, in March 2024, Lee Health, a US-based non-profit public health system, introduced Lyphosterol, a soft gel capsule designed to support cardiovascular health. This product combines gamma oryzanol and aged garlic extract to help balance cholesterol and triglyceride levels, stabilize heart rhythms, and protect against free radical damage.

Major companies operating in the oryzanol market are Merck KGaA, Fujifilm Group, Huadong Medicine Co. Ltd., Jiangsu Hengrui Pharmaceuticals, Swanson Health Products, Oryza Oil and Fat Chemical Co., ChromaDex Inc., Sunrise New Energy, Organic Herb Inc., Shanghai Freemen LLC, Sure Chemicals Co. Ltd., Nutra Green Biotechnology, Tokyo Chemical Industry, NutriScience Innovations LLC, Kingherbs Limited, Ricela Health Foods Ltd., Kangcare Bioindustry Co., Honson Pharmatech Group, Puyer Group, Source Natural Foods & Herbal Supplements Limited, Wuxi Accobio Biotech Inc., Grupo Lala S.A.B, Henry Lamotte Oils, Shaanxi Pioneer Biotech Co. Ltd, Fengchen Group Co. Ltd., TSUNO Rice Fine Chemicals Co. Ltd., Xi’an Gaoyuan Bio-Chem Co. Ltd, Zheijang Delekang Food Co.

North America was the largest region in the oryzanol market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oryzanol market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the oryzanol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The oryzanol market consists of sales of oryzanol supplements, oryzanol enriched foods, oryzanol creams and lotions, rice bran extract. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.